BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  BioCapital

  Boosting Proteins Could Help Remove Tangles and Plaques Associated With Alzheimer’s

  Research conducted at Temple University is showing a potential new way to address the onset of Alzheimer’s disease through the use of pharmacological chaperones.

  January 22, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  FDA

  Horizon Therapeutics Wins FDA Approval for First Thyroid Eye Disease Treatment

  Tuesday afternoon the U.S. Food and Drug Administration approved Tepezza (teprotumumab-trbw) as the first treatment for this condition.

  January 22, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  China Coronavirus Update: What it is, How Dangerous it is, What is Being Done

  The new coronavirus infection appears connected to a seafood market in Wuhan City in China, which has more a population of more than 11 million.

  January 22, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  BioSpace Global Roundup, Jan. 23

  Companies from across the globe provide updates on their businesses and pipelines.

  January 22, 2020

   · 

  7 min read

   · 

  Alex Keown
• 

  Policy

  FDA Publishes Initial Rejection Letter of Sarepta’s Vyondys 53 for DMD

  The CRL not only brings up the potential toxicities of the drug, but also raises questions about the drug’s efficacy.

  January 22, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  2020 Could be a Defining Year for SQZ Biotech

  Armon Sharei, chief executive officer of SQZ Biotech, said 2020 is going to be an exciting year for the company as it anticipates having clinical data available from its first trial by the end of this year.

  January 22, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  The Next Big Thing in Birth Control: Amphora Offers Women a Missing Option

  Amphora is a viscous and bioadhesive contraceptive, packaged in a prefilled applicator.

  January 22, 2020

   · 

  3 min read

   · 

  Elizabeth Glasure
• 

  Employer Resources

  Why Should Professionals Seek out Employers with Diverse Workforces?

  Let’s review the reasons why professionals seek out employers with diverse workforces.

  January 22, 2020

   · 

  5 min read

   · 

  Don Potochny
• 

  Few Companies Focus on Growing Threat of Superbugs: Report

  A report released by the Access to Medicine Foundation shines a light on just how small the pipeline and discovery programs aimed at superbugs are.

  January 22, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Deal or No Deal: Uncertainty Surrounding Brexit Continues

  The Withdrawal Agreement Bill passed in Britain’s House of Commons on Thursday, setting January 31st as the UK’s departure date from the EU, and potentially wrapping up one part of the three-year quagmire that is Brexit.

  January 22, 2020

   · 

  3 min read

   · 

  Gina Hagler